Magnetic resonance imaging-guided adoptive cellular immunotherapy of central nervous system tumors with a T1 contrast agent.
about
Molecular imaging of cell-based cancer immunotherapy.A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging.Trial watch: Dendritic cell-based interventions for cancer therapyMRI & MRS assessment of the role of the tumour microenvironment in response to therapy.MRI-guided interventional natural killer cell delivery for liver tumor treatment.
P2860
Magnetic resonance imaging-guided adoptive cellular immunotherapy of central nervous system tumors with a T1 contrast agent.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@ast
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@en
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@nl
type
label
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@ast
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@en
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@nl
prefLabel
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@ast
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@en
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@nl
P2093
P2860
P356
P1476
Magnetic resonance imaging-gui ...... mors with a T1 contrast agent.
@en
P2093
Daniel P Steed
Erik C Wiener
Laima Spokauskiene
Norma Arbujas
Patricia Griffin
Raghvendra S Sengar
William H Chambers
P2860
P304
P356
10.1002/MRM.22030
P577
2009-09-01T00:00:00Z